AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.670
-0.040 (-1.48%)
At close: Nov 20, 2024, 4:00 PM
2.630
-0.040 (-1.50%)
Pre-market: Nov 21, 2024, 4:59 AM EST
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $788.63 million as of November 21, 2024. Its market cap has decreased by -39.27% in one year.
Market Cap
788.63M
Enterprise Value
216.89M
1-Year Change
-39.27%
Ranking
Category
Stock Price
$2.67
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $788.63M, a decrease of -94.97%. That is a compound annual growth rate of -53.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 800.44M | -51.69% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | 10.83B | -30.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Capricor Therapeutics | 839.37M |
| Healthcare Services Group | 832.59M |
| Rapport Therapeutics | 814.92M |
| Castle Biosciences | 808.57M |
| Relay Therapeutics | 803.44M |
| Cytek Biosciences | 789.61M |
| Erasca | 788.81M |
| Autolus Therapeutics | 785.06M |